These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4081678)

  • 1. [How can we improve long-term anticoagulation?].
    Beck EA
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1495-500. PubMed ID: 4081678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability of INR in patients on stable long-term treatment with phenprocoumon and acenocoumarol and implications for analytical quality requirements.
    van Geest-Daalderop JH; Péquériaux NC; van den Besselaar AM
    Thromb Haemost; 2009 Sep; 102(3):588-92. PubMed ID: 19718481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral anticoagulation with vitamin K antagonists].
    Alberio L
    Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [General practitioner's considerations if INR doesn't change].
    Dick A; Spannagl M
    MMW Fortschr Med; 2009 Jun; 151(26-29):32-3. PubMed ID: 19739544
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial.
    Gadisseur AP; Breukink-Engbers WG; van der Meer FJ; van den Besselaar AM; Sturk A; Rosendaal FR
    Arch Intern Med; 2003 Nov; 163(21):2639-46. PubMed ID: 14638565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is optimal anticoagulation possible in ambulatory practice? Report on a retrospective 5-year study of a cardiology practice].
    von Bertrab R
    Schweiz Med Wochenschr; 1985 Aug; 115(31-32):1092-105. PubMed ID: 4048907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
    Rombouts EK; Rosendaal FR; van der Meer FJ
    Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulation therapy in children.
    Bonduel MM
    Thromb Res; 2006; 118(1):85-94. PubMed ID: 16709477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Established anticoagulants in secondary haemostasis--Vitamin K antagonists, heparins].
    Langer E; Ziemer S
    Hamostaseologie; 2009 Aug; 29(3):241-6. PubMed ID: 19644603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extent and quality of anti-coagulation treatment with coumarin derivatives by the Dutch Thrombosis Services].
    van Geest-Daalderop JH; Sturk A; Levi M; Adriaansen HJ
    Ned Tijdschr Geneeskd; 2004 Apr; 148(15):730-5. PubMed ID: 15119208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
    van den Besselaar AM
    J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of Quick/INR values of whole capillary blood (CoaguChek Plus) and venous citrate plasma in patients with and without oral anticoagulation].
    Burri S; Demarmels Biasiutti F; Lämmle B; Wuillemin WA
    Schweiz Med Wochenschr; 1998 Oct; 128(44):1723-9. PubMed ID: 9846345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation.
    Tripodi A; Bressi C; Carpenedo M; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Res; 2004; 113(1):35-40. PubMed ID: 15081563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of therapeutic quality control in a long-term anticoagulant trial in post-myocardial infarction patients.
    Azar AJ; Deckers JW; Rosendaal FR; van Bergen PF; van der Meer FJ; Jonker JJ; Briët E
    Thromb Haemost; 1994 Sep; 72(3):347-51. PubMed ID: 7855782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use decreases coagulation in users of vitamin K antagonists.
    van Rein N; Biedermann JS; Bonafacio SM; Kruip MJ; van der Meer FJ; Lijfering WM
    Eur J Clin Pharmacol; 2016 Dec; 72(12):1441-1447. PubMed ID: 27709253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary vitamin K intake and anticoagulation in elderly patients.
    Rohde LE; de Assis MC; Rabelo ER
    Curr Opin Clin Nutr Metab Care; 2007 Jan; 10(1):1-5. PubMed ID: 17143047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Importance of standardization in the biological monitoring of anti-vitamin K therapy].
    Forestier F; Boneu B; Potron G; Boisseau M; Coqueret B; Saffar S; Chambrette B
    Nouv Rev Fr Hematol (1978); 1986; 28(3):157-62. PubMed ID: 3748800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.